Kabra Drugs Ltd

Kabra Drugs Ltd

₹ 9.59 0.00%
18 Nov - close price
About

Incorporated in 1989, Kabra Drugs Limited is engaged in the business of Permaculture manufacturing and trading in pharma related products.

Key Points

Product Profile:[1]
a) Cardiovascular Drugs[2]
b) Anti-infective Drugs[3]
c) Oncology Drugs[4]
d) Gastroenterological Drugs[5]
e) Hormonal Drugs[6]
f) Miscellaneous Drugs[7]
g) Active Pharmaceutical Ingredients[8]

  • Market Cap 9.67 Cr.
  • Current Price 9.59
  • High / Low 9.59 / 4.87
  • Stock P/E
  • Book Value 3.25
  • Dividend Yield 0.00 %
  • ROCE -43.0 %
  • ROE -423 %
  • Face Value 10.0

Pros

  • Company has reduced debt.

Cons

  • Stock is trading at 2.95 times its book value
  • Company has low interest coverage ratio.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Figures in Rs. Crores

Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
0.03 0.04 0.05 0.07 0.07 0.06 0.14 0.12 0.13 0.11 0.37 0.55 0.40
Operating Profit -0.03 -0.04 -0.05 -0.07 -0.07 -0.06 -0.14 -0.12 -0.13 -0.11 -0.37 -0.55 -0.40
OPM %
0.00 0.00 0.00 0.00 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Depreciation 0.00 0.00 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Profit before tax -0.03 -0.04 -0.06 -0.07 -0.06 -0.06 -0.14 -0.12 -0.13 -0.11 -0.37 -0.55 -0.40
Tax % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
-0.03 -0.04 -0.06 -0.07 -0.06 -0.06 -0.14 -0.12 -0.13 -0.11 -0.37 -0.55 -0.40
EPS in Rs -0.07 -0.09 -0.14 -0.16 -0.14 -0.14 -0.32 -0.27 -0.30 -0.25 -0.84 -1.25 -0.40
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM
10.17 11.42 8.24 9.59 7.61 1.81 -0.04 0.00 0.00 0.00 0.00 0.00 0.00
9.61 10.84 7.77 9.14 7.17 2.84 0.09 0.05 0.15 0.18 0.35 0.74 1.43
Operating Profit 0.56 0.58 0.47 0.45 0.44 -1.03 -0.13 -0.05 -0.15 -0.18 -0.35 -0.74 -1.43
OPM % 5.51% 5.08% 5.70% 4.69% 5.78% -56.91% -150.00% -3,400.00%
-0.02 -0.03 0.01 0.02 0.11 -0.94 0.01 0.02 0.00 0.00 0.01 0.00 0.00
Interest 0.06 0.07 0.14 0.18 0.17 0.25 0.01 0.00 0.00 0.00 0.00 0.00 0.00
Depreciation 0.26 0.26 0.23 0.24 0.24 0.14 0.03 0.03 0.03 0.01 0.00 0.00 0.00
Profit before tax 0.22 0.22 0.11 0.05 0.14 -2.36 -0.16 -0.06 -0.18 -0.19 -0.34 -0.74 -1.43
Tax % 31.82% 59.09% 36.36% 40.00% 7.14% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
0.15 0.09 0.07 0.03 0.13 -2.36 -0.16 -0.06 -0.18 -0.19 -0.34 -0.74 -1.43
EPS in Rs 0.34 0.21 0.16 0.07 0.30 -5.38 -0.36 -0.14 -0.41 -0.43 -0.77 -1.69 -2.74
Dividend Payout % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: %
TTM: %
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: -218%
Stock Price CAGR
10 Years: -17%
5 Years: 62%
3 Years: 20%
1 Year: 87%
Return on Equity
10 Years: %
5 Years: %
3 Years: %
Last Year: -423%

Balance Sheet

Figures in Rs. Crores

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Sep 2024
Equity Capital 4.39 4.39 4.39 4.39 4.39 4.39 4.39 4.39 4.39 4.39 4.39 4.39 10.08
Reserves -1.54 -1.46 -1.78 -1.76 -1.84 -4.19 -4.36 -4.42 -4.60 -4.78 -5.12 -3.31 -6.80
2.80 3.01 2.81 2.39 1.80 0.70 0.67 0.65 0.90 1.03 1.38 1.71 0.64
3.04 3.27 3.12 4.15 2.03 0.80 0.78 0.79 0.71 0.09 0.05 1.78 1.03
Total Liabilities 8.69 9.21 8.54 9.17 6.38 1.70 1.48 1.41 1.40 0.73 0.70 4.57 4.95
3.51 3.30 2.78 2.73 2.48 0.11 0.08 0.04 0.01 0.00 0.00 0.00 0.04
CWIP 0.00 0.00 0.10 0.21 0.21 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
5.18 5.91 5.66 6.23 3.69 1.59 1.40 1.37 1.39 0.73 0.70 4.57 4.91
Total Assets 8.69 9.21 8.54 9.17 6.38 1.70 1.48 1.41 1.40 0.73 0.70 4.57 4.95

Cash Flows

Figures in Rs. Crores

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
-1.43 0.00 -0.22 0.28 0.31 -0.12 -0.18 -0.05 -0.25 -0.13 -0.35 -0.21
-0.03 -0.14 -0.20 -0.29 0.01 1.50 0.07 0.06 0.00 0.00 0.00 0.00
1.68 0.14 0.58 -0.27 -0.32 -1.35 0.00 -0.02 0.25 0.13 0.36 2.88
Net Cash Flow 0.22 0.00 0.16 -0.28 0.00 0.04 -0.10 0.00 0.00 -0.01 0.00 2.67

Ratios

Figures in Rs. Crores

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 138.89 146.38 198.00 204.00 141.49 254.09 -11,406.25
Inventory Days 26.25 31.67 25.58 16.04 16.73 0.00 0.00
Days Payable 98.18 79.17 129.78 139.88 97.33
Cash Conversion Cycle 66.96 98.88 93.81 80.16 60.89 254.09 -11,406.25
Working Capital Days 66.76 75.43 92.58 73.46 65.23 102.85 5,018.75
ROCE % 5.52% 4.40% 4.41% 6.62% -44.19% -18.75% -9.09% -27.48% -28.57% -52.71% -43.02%

Shareholding Pattern

Numbers in percentages

Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
100.00% 100.00% 100.00% 99.99% 100.00% 100.01% 100.01% 100.01% 100.01% 100.01% 100.01% 100.01%
No. of Shareholders 7,3997,3917,4287,4037,4017,4247,4207,4157,3967,3647,3367,367

Documents